User profiles for M. Scarpa
Marco ScarpaGeneral Surgery Unit, University Hospital of Padova, Padova, Italy Verified email at aopd.veneto.it Cited by 7975 |
[HTML][HTML] Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
JE Wraith, M Scarpa, M Beck, OA Bodamer… - European journal of …, 2008 - Springer
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X-linked recessive
disease caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to …
disease caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to …
Immunologic privilege in the central nervous system and the blood–brain barrier
…, JR Ohlfest, A Prat, M Scarpa… - Journal of Cerebral …, 2013 - journals.sagepub.com
The brain is in many ways an immunologically and pharmacologically privileged site. The
blood–brain barrier (BBB) of the cerebrovascular endothelium and its participation in the …
blood–brain barrier (BBB) of the cerebrovascular endothelium and its participation in the …
[HTML][HTML] Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
EA Braunlin, PR Harmatz, M Scarpa… - Journal of inherited …, 2011 - Springer
The mucopolysaccharidoses (MPSs) are inherited lysosomal storage disorders caused by
the absence of functional enzymes that contribute to the degradation of glycosaminoglycans (…
the absence of functional enzymes that contribute to the degradation of glycosaminoglycans (…
[HTML][HTML] A precision measurement of direct CP violation in the decay of neutral kaons into two pions
…, M Martini, L Masetti, F Petrucci, M Savrie, M Scarpa… - Physics Letters B, 2002 - Elsevier
The direct CP violation parameter Re(ϵ′/ϵ) has been measured from the decay rates of
neutral kaons into two pions using the NA48 detector at the CERN SPS. The 2001 running …
neutral kaons into two pions using the NA48 detector at the CERN SPS. The 2001 running …
[HTML][HTML] Search for the dark photon in π0 decays
A sample of 1.69 × 10 7 fully reconstructed π 0 → γ e + e − decay candidates collected by the
NA48/2 experiment at CERN in 2003–2004 is analyzed to search for the dark photon ( A ′ …
NA48/2 experiment at CERN in 2003–2004 is analyzed to search for the dark photon ( A ′ …
The beam and detector for the NA48 neutral kaon CP violation experiment at CERN
…, M Porcu, F Rossi, M Savrie, M Scarpa… - Nuclear Instruments and …, 2007 - Elsevier
… 5), the vacuum chamber containing the two beams opened up into a cylindrical tank of
total length 89 m and inner diameter 1.92 m increasing in two steps up to 2.40 m at the end …
total length 89 m and inner diameter 1.92 m increasing in two steps up to 2.40 m at the end …
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N …
…, JE Wraith, M Beck, L Arash, M Scarpa… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The objective of this Phase 3 study was to confirm the efficacy and safety of
recombinant human arylsulfatase B (rhASB) treatment of mucopolysaccharidosis type VI (MPS …
recombinant human arylsulfatase B (rhASB) treatment of mucopolysaccharidosis type VI (MPS …
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
…, M Scarpa, C Fiocchi, M Vecchi… - Proceedings of the …, 2010 - National Acad Sciences
IL-33 is a novel member of the IL-1 family and ligand for the IL-1 receptor-related protein,
ST2. Recent evidence suggests that the IL-33/ST2 axis plays a critical role in several …
ST2. Recent evidence suggests that the IL-33/ST2 axis plays a critical role in several …
Influence of different types of grasping on the transport component of prehension movements
The main aim of the present study was to clarify whether different types of grasping may affect
the transport component of prehension movements. To this purpose two experiments were …
the transport component of prehension movements. To this purpose two experiments were …
[HTML][HTML] A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency
…, S Nightingale, H Peters, M Scarpa… - … England Journal of …, 2015 - Mass Medical Soc
Background Lysosomal acid lipase is an essential lipid-metabolizing enzyme that breaks
down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial …
down endocytosed lipid particles and regulates lipid metabolism. We conducted a phase 3 trial …